MedPath

The use of an enriched environment post stroke

Not Applicable
Recruiting
Conditions
Stroke
Neurological - Other neurological disorders
Stroke - Haemorrhagic
Stroke - Ischaemic
Registration Number
ACTRN12611000629932
Lead Sponsor
niversity of Newcastle
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
28
Inclusion Criteria

mRS > or equal to 2
able to follow one step commands
able to stand with the assistance of 2
no behavioural issues influencing the ability to participate in 'normal' rehabilitation

Exclusion Criteria

Becomes acutely unwell, preventing participation in the rehabilitation process

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Activity levels: Proportion of the day spent in physical, cognitive and social activity (%). Behavioural mapping tool was used to estimate the proportion of time spent in each activity during 4, 12 hour days (1 weekday and 1 weekend day in the first week, with the same weekday and weekend day repeated 2 weeks later).<br>Behavioural mapping observations were made every ten minutes in which the location, people present and activity were noted for each participant.[Baseline and 2 weeks later.]
Secondary Outcome Measures
NameTimeMethod
Function (Functional Independence Measure),[Baseline and 2 weeks later];Cognitive Function (using a battery of tests including the Montreal Cognitive Assessment)[Baseline and 2-3 weeks later (control group, 2-3 week period), enrichment group, post enrichment period, which was usually again, a 2-3 week period from baseline assessments)];Qualitative interview to gain a further understanding of the patient's experience in rehabilitation (enriched group only)[Qualitative interview- end of 2 week enrichment period];Quality of Life (Assessment of Quality of Life (AQoL) survey[AQoL- approx one month post discharge from hospital];boredom (purposely designed likert survey)[Baseline and 2 weeks later];mood (PHQ-9)[Baseline and 2 weeks later]
© Copyright 2025. All Rights Reserved by MedPath